title: Acceleration of wound healing with topically applied deoxyribonucleosides.
abstract: OBJECTIVE
  We hypothesized that a topical mixture of purified deoxyribonucleosides would accelerate wound healing in an open wound model.
  
  
  METHODS
  Full-thickness 6-mm wounds were made on the ears of young adult rabbits. In some experiments, 2 of the 3 arteries in each ear were divided to induce wound ischemia.
  
  
  METHODS
  An equiweight mixture containing all 4 of the major deoxyribonucleosides (deoxyadenosine, deoxycytidine, deoxyguanosine, and thymidine), designated PN105, or other subgroups of deoxyribonucleosides, or vehicle (saline) was applied to wounds on 1 ear every 2 days, with the other ear serving as a control.
  
  
  METHODS
  Wound tissue was processed for histological examination 7 days after the initial wounding. Granulation tissue formation and epithelialization were measured in histological cross sections of wounds.
  
  
  RESULTS
  Treatment of wounds with PN105 resulted in a 191% increase in total new granulation tissue (P<.05) and a higher incidence of complete wound reepithelialization (67% vs 37%; P<.05) when compared with controls, and a similar increase under ischemic conditions on day 7. Wound ischemia markedly impairs healing; PN 105 treatment resulted in a 242% increase in the amount of new granulation tissue formed by day 7 in ischemic wounds, relative to the appropriate controls (P<.05). All 4 of the major deoxyribonucleosides were required for optimum activity; mixtures with 3 or 2 were less active or inactive.
  
  
  CONCLUSIONS
  Topically applied deoxyribonucleosides reproducibly accelerate wound healing in normal and ischemic wounds, and to a magnitude equivalent to that of recombinant growth factors such as platelet-derived growth factor, previously studied in this model. In view of their safety, availability, and efficacy, deoxyribonucleosides hold considerable promise for improving healing of chronic wounds.
mesh_terms: D000180:Acrylic Resins / Q000494:pharmacology; D000287:Administration, Topical; D000818:Animals; D003853:Deoxyribonucleosides / Q000494:pharmacology*; D005260:Female; D011817:Rabbits; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects*